Perioperative changes in peripheral regulatory B cells of patients with esophageal cancer

Molecular Medicine Reports

Volumn 10, Issue 3, 2014, Pages 1525-1530

  Shi, Jiazhen ^a   Li, Shibao ^a,b   Zhou, Yan ^a   Wang, Lixin ^c   Wen, Jiangtao ^a   Wang, Yonghong ^a   Kang, Zhihua ^b  

^a Li anyungang Second People's Hospital   (China)

^b FUDAN UNIVERSITY   (China)

^c MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Esophageal cancer; Forkhead winged helix protein; Interleukin 10; Regulatory B cells; Transforming growth factor

Indexed keywords

CD19 ANTIGEN; CD5 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; FOXP3 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER GROWTH; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PERIPHERAL REGULATORY B LYMPHOCYTE; PHENOTYPE; PROTEIN EXPRESSION; RADICAL RESECTION; CASE CONTROL STUDY; CYTOLOGY; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; ANTIGENS, CD19; ANTIGENS, CD5; B-LYMPHOCYTES, REGULATORY; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; PERIOPERATIVE PERIOD; TRANSFORMING GROWTH FACTOR BETA;

EID: 84905457515     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2347     Document Type: Article

References (37)

1. Kamangar F, Dores GM and Andeson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150, 2006. (Pubitemid 46655601)
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
3. Enzinger PC and Mayer RJ: Esophageal Cancer. N Engl J Med 349: 2241-2252, 2003. (Pubitemid 37485141)
4. Watanabe R, Ishiura N, Nakashima H, Kuwano Y, Okochi H, Tamaki K, Sato S, Tedder TF and Fujimoto M: Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol 184: 4801-4809, 2010.
5. Olkhanud PB, Damdinsuren B, Bodogai M, Gress RE, Sen R, Wejksza K, Malchinkhuu E, Wersto RP and Biragyn A: Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T-regulatory cells. Cancer Res 71: 3505-3515, 2011.
6. Schioppa T, Moore R, Thompson RG, Rosser EC, Kulbe H, Nedospasov S, Mauri C, Coussens LM and Balkwill FR: B regulatory cells and the tumor promoting actions of TNF-α during squamous carcinogenesis. Proc Natl Acad Sci USA 108: 10662-10667, 2011.
7. Huang C and Fu ZX: Localization of IL-17+Foxp3+ T cells in esophageal cancer. Immunol Invest 40: 400-412, 2011.
8. Mauri C and Bosma A: Immune regulatory function of B cells. Annu Rev Immunol 30: 221-241, 2012.
9. Lund FE and Randall TD: Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat Rev Immunol 10: 236-247, 2010.
10. Noh G and Lee JH: Regulatory B cells and allergic diseases. Allergy Asthma Immunol Res 3: 168-177, 2011.
11. Watanabe R, Fujimoto M, Ishiura N, Kuwano Y, Nakashima H, Yazawa N, Okochi H, Sato S, Tedder TF and Tamaki K: CD19 expression in B cells is important for suppression of contact hypersensitivity. Am J Pathol 171: 560-570, 2007. (Pubitemid 47344688)
12. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M and Tedder TF: A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650, 2008.
13. Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M and Tedder TF: Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 118: 3420-3430, 2008.
14. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D and Anderton SM: B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3: 944-950, 2002. (Pubitemid 35154008)
15. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS and Bhan AK: Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230, 2002. (Pubitemid 34211962)
16. Fillatreau S, Gray D and Anderton SM: Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol 8: 391-397, 2008. (Pubitemid 351595221)
17. DiLillo DJ, Matsushita T and Tedder TF: B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann NY Acad Sci 1183: 38-57, 2010.
18. Mauri C and Ehrenstein MR: The 'short' history of regulatory B cells. Trends Immunol 29: 34-40, 2008.
19. Mizoguchi A and Bhan AK: A case for regulatory B cells. J Immunol 176: 705-710, 2006. (Pubitemid 43099663)
20. Mosser D and Zhang X: Interleukin-10: new perspectives on an old cytokine. Immunol Rev 226: 205-218, 2008.
21. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A (eds): AJCC Cancer Staging Manual. Seventh edition. Springer, New York, NY, 2010.
22. Inoue S, Leitner WW, Golding B and Scott D: Inhibitory effects of B cells on antitumor immunity. Cancer Res 66: 7741-7747, 2006. (Pubitemid 44289234)
23. Chen T, Song D, Min Z, et al: Perioperative dynamic alterations in peripheral regulatory T and B cells in patients with hepatocellular carcinoma. J Transl Med 10: 14, 2012.
24. Im SH, Hueber A, Monticelli S, Kang KH and Rao A: Chromatin-level regulation of the IL10 gene in T cells. J Biol Chem 279: 46818-46825, 2004. (Pubitemid 39518332)
25. Lee JH, Noh J, Noh G, Choi WS and Lee SS: IL-10 is predominantly produced by the CD19(low)CD5(+) regulatory B cell subpopulation: characterization of CD19(high) and CD19(low) subpopulations of CD5(+) B cells. Yonsei Med J 52: 851-855, 2011.
26. Lee JH, Noh J, Noh G, Kim HS, Mun SH, Choi WS, Cho S and Lee S: Allergen-specific B cell subset responses in cow's milk allergy of late eczematous reactions in atopic dermatitis. Cell Immunol 262: 44-51, 2010.
27. Itoh S and Itoh F: Implication of TGF-β as a survival factor during tumour development. J Biochem 151: 559-562, 2012.
28. Hoshino Y, Katsuno Y, Ehata S and Miyazono K: Autocrine TGF-β protects breast cancer cells from apoptosis through reduction of BH3-only protein, Bim. J Biochem 149: 55-65, 2011.
29. Edlund S, Bu S, Schuster N, Aspenström P, Heuchel R, Heldin NE, ten Dijke P, Heldin CH and Landström M: Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3. Mol Biol Cell 14: 529-544, 2003. (Pubitemid 36237014)
30. Miller AV, Alvarez SE, Spiegel S and Lebman DA. Sphingosine kinases and sphingosine-1-phosphate are critical for transforming growth factor beta-induced extracellular signal-regulated kinase 1 and 2 activation and promotion of migration and invasion of esophageal cancer cells. Mol Cell Biol 28: 4142-4151, 2008. (Pubitemid 351812997)
31. Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A and Kaufman DL: Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 167: 1081-1089, 2001. (Pubitemid 32660868)
32. Lee JH, Noh J, Noh G, Choi WS, Cho S and Lee SS: Allergen-specific transforming growth factor-β-producing CD19+CD5+ regulatory B-cell (Br3) responses in human late eczematous allergic reactions to cow's milk. J Interferon Cytokine Res 31: 441-449, 2011.
33. Hori S, Nomura T and Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061, 2003. (Pubitemid 36222930)
34. Wang G, Liu G, Liu Y, Li X and Su Z: FOXP3 Expression in esophageal cancer cells is associated with poor prognosis in esophageal cancer. Hepatogastroenterology 59: 2186-2191, 2012.
35. Noh J, Choi WS, Noh G and Lee JH: Presence of Foxp3-expressing CD19(+)CD5(+) B Cells in human peripheral blood mononuclear cells: Human CD19(+)CD5(+)Foxp3(+) regulatory B cell (Breg). Immune Netw 10: 247-249, 2010.
36. Baumgartner C, Osl M, Netzer M and Baumgartner D: Bioinformatic-driven search for metabolic biomarkers in disease. J Clin Bioinforma 1: 2, 2011.
37. Wang X and Liotta L: Clinical bioinformatics: a new emerging science. J Clin Bioinforma 1: 1, 2011.